Discusses Phase III Data for Intismeran and Advances in Cancer Immunotherapy October 24, 2026 1:00 PM EDTCompany ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results